CareMetx Acquires Pharmacy Operations from Cencora, Significantly
Expanding Its Patient Access Platform
April 27, 2026 07:02 ET | Source: CareMetx, LLC
BETHESDA, MD, April 27, 2026 (GLOBE NEWSWIRE) — CareMetx, the
market-leading technology-enabled patient services provider,
today announced the acquisition of Cencora’s U.S. Hub consulting
services operations previously conducted under the Lash Group and
including TheraCom free goods pharmacy. The transaction
substantially increases CareMetx’s operational scale and
accelerates the company’s ability to serve an expanded portfolio
of pharmaceutical brands and patient populations across pharmacy,
medical, and dual benefit products.
The acquired operations encompass full-service hub operations,
patient access staffing infrastructure, and free goods pharmacy
fulfillment, directly extending CareMetx’s end-to-end platform
and strengthening its position as one of the most comprehensive
patient access solutions providers in the specialty therapy
market.
Expanding the Platform Where It Matters Most
With 15 years of dedicated investment in patient services,
CareMetx brings a proven technology platform, expanding AI and
workflow automation capabilities, and a track record of
measurable program improvement across more than 155
pharmaceutical brands. The acquired operations add experienced
teams, established client relationships, and complementary
therapeutic expertise that strengthen what CareMetx can deliver
for every manufacturer it serves.
The timing reflects where the industry is headed. Payor
complexity is increasing, provider burden is growing, and
manufacturers need partners who invest ahead of the curve,
deploying automation where it reduces friction and brings
intelligence to decisions that still rely too heavily on manual
intervention. The acquisition of Cencora’s U.S. Hub consulting
services operations augments CareMetx’s existing end-to-end
platform with even greater scale.
With increasing demand for technology-forward hub services,
CareMetx was selected as the ideal partner to deliver a smooth
transition for patients, providers and clients currently served
by Cencora’s U.S. Hub consulting services business. Cencora will
continue to rely on CareMetx as a preferred partner for patient
services in the United States.
“This acquisition reflects both the growth of CareMetx and the
confidence our clients and partners place in our model,” said
Greg Morris, President & Chief Strategy Officer, CareMetx.
“Patient services is – and has always been – our primary
strategic focus. We’ve spent 15 years building a platform that
turns scattered signals into synchronized action, and we invest a
significant portion of revenue each year into the technology and
people that make that possible. The teams, programs, and patients
coming to CareMetx will benefit from that commitment from day
one, and our goal is that every client experiences this
transition as a step forward, not just a change in name. And as
demand for technology-forward hub services increases, we believe
CareMetx is now even more strongly positioned to deepen our focus
on innovation for our clients and advance our longstanding
mission to meaningfully improve patient outcomes.”
CareMetx is committed to delivering a smooth transition for the
patients, providers and clients currently served by Cencora’s
U.S. Hub consulting services operations. To ensure continuity of
care and a seamless client experience, CareMetx has assembled a
dedicated internal transition team led by Michael Sullivan, Chief
Integration Officer, and Shabbir Ahmed, Chief Growth Officer.
About CareMetx
Headquartered in Bethesda, Maryland, CareMetx, LLC is a leading
technology-enabled patient services provider facilitating patient
access to specialty medications. With 15 years serving
pharmaceutical, biotechnology and device manufacturers, CareMetx
combines proprietary technology and infrastructure, intelligent
automation, and compassionate patient advocacy to reduce
barriers, accelerate time to therapy, and improve outcomes across
every stage of the treatment journey for millions of patients
each year.
For more information, visit www.caremetx.com.
The M&A market for healthcare companies continues to build on STRATEGIC opportunities and a fragmented market. Consolidations along with unprecedented demand are driving scale across the continuum of care. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
